Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleResearch Article

Clinical Research Regarding the Ratio of Lymph Node Metastasis and the Reasonable Extent of Lymphadenectomy in Middle Third Thoracic Esophageal Squamous Cell Carcinoma

Ming-ran XIE, Peng LIN, Xu ZHANG, Jie-xin CHEN, Yong-bin LIN, Zhe-sheng WEN, Tie-hua RONG, Xiao-dong LI, Jun-ye WANG and Hui YU
Clinical Oncology and Cancer Research February 2010, 7 (1) 33-38; DOI: https://doi.org/10.1007/s11805-010-0033-y
Ming-ran XIE
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng LIN
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: linpengsir{at}hotmail.com
Xu ZHANG
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie-xin CHEN
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-bin LIN
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhe-sheng WEN
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tie-hua RONG
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-dong LI
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-ye WANG
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui YU
State Key Laboratory of Oncology in South China, Department of Thoracic Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. ↵
    1. Bumm R,
    2. Wong J.
    More or less surgery for esophageal cancer: extent of lymphadenectomy in esophagectomy for squamous cell esophageal carcinoma: how much is necessary. Dis Esophagus 1994; 7: 151-155.
    OpenUrl
  2. ↵
    1. Feng QL,
    2. Shang SY,
    3. Zhao XJ.
    The study on metastasis of lymph nodes for carcinoma of the thoracic esophagus. Zhongguo Zhongliu Linchuang 2005; 32: 706-708 (Chinese).
    OpenUrl
  3. ↵
    1. Siewert J R,
    2. Stein H J,
    3. Feith M, et al.
    Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234: 360-367; discussion 368-369.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Lu ZM,
    2. Zhang H,
    3. Wang MH, et al.
    Lymphatic Metastasis Intensity of and Lymphadenectomy for Thoracic Esophageal Squamous Cell Carcinoma. Aizheng 2006; 25: 604-608 (Chinese).
    OpenUrl
    1. Wu J,
    2. Chai Y,
    3. Zhou XM, et al.
    Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus. Aizheng 2007; 26: 307-311 (Chinese).
    OpenUrl
  5. ↵
    1. Li H,
    2. Zhang Y,
    3. Cai H, et al.
    Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy. Eur Surg Res 2007; 39: 1-6.
    OpenUrlPubMed
  6. ↵
    1. Rong TH,
    2. Lin P,
    3. Wu YL.
    Clinical study on lymph node metastasis of thoracic esophageal carcinoma. Zhonghua Xiongxinxueguan Waike Zazhi 1994; 10: 242-244 (Chinese).
    OpenUrl
  7. ↵
    1. Eloubeidi MA,
    2. Desmond R,
    3. Arguedas MR, et al.
    Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-1443.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. An FS,
    2. Huang JQ,
    3. Chen SH.
    Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis. Aizheng 2003; 22: 974-977 (Chinese).
    OpenUrl
  9. ↵
    1. Wang YG,
    2. Wang LJ,
    3. Zhang DC, et al.
    Characteristics of lymph node metastases of squamous cell carcinoma of the thoracic esophagus and its clinical significance. Zhonghua Zhongliu Zazhi 2000; 22: 241-243 (Chinese).
    OpenUrl
  10. ↵
    1. Kato H,
    2. Fukuchi M,
    3. Miyazaki T, et al.
    Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy. Anticancer Res 2005; 25: 3461-3467.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Katayama A,
    2. Mafune K,
    3. Tanaka Y, et al.
    Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg 2003; 196: 866-873.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Shimada H,
    2. Okazumi S,
    3. Matsubara H, et al.
    Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 2006; 30: 1441-1449.
    OpenUrlCrossRefPubMedWeb of Science
    1. Lerut T,
    2. Nafteux P,
    3. Moons J, et al.
    Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004; 240: 962-972.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Shimada H,
    2. Okazumi S,
    3. Shiratori T, et al.
    Mode of lymphadenectomy and surgical outcome of upper thoracic esophageal squamous cell carcinoma. J Gastrointest Surg 2009; 13: 619-625.
    OpenUrlPubMed
  14. ↵
    1. Watanabe H,
    2. Kato H,
    3. Tachimori Y.
    Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res 2000; 155: 123-133.
    OpenUrlPubMed
  15. ↵
    1. Law S,
    2. Wong J.
    Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001; 14: 98-103.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Hsu CP,
    2. Chen CY,
    3. Hsia JY, et al.
    Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus. Eur J Cardiothorac Surg 2001; 19: 10-13.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Zhang HL,
    2. He M,
    3. Zhang FL, et al.
    The significance of the number of lymph node metastasis in patient survival and UICC-TNM classification of esophageal carcinoma. Zhongguo Zhongliu Linchuang 2008; 35: 252-255 (Chinese).
    OpenUrl
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 7 (1)
Clinical Oncology and Cancer Research
Vol. 7, Issue 1
1 Feb 2010
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Research Regarding the Ratio of Lymph Node Metastasis and the Reasonable Extent of Lymphadenectomy in Middle Third Thoracic Esophageal Squamous Cell Carcinoma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Clinical Research Regarding the Ratio of Lymph Node Metastasis and the Reasonable Extent of Lymphadenectomy in Middle Third Thoracic Esophageal Squamous Cell Carcinoma
Ming-ran XIE, Peng LIN, Xu ZHANG, Jie-xin CHEN, Yong-bin LIN, Zhe-sheng WEN, Tie-hua RONG, Xiao-dong LI, Jun-ye WANG, Hui YU
Clinical Oncology and Cancer Research Feb 2010, 7 (1) 33-38; DOI: 10.1007/s11805-010-0033-y

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Research Regarding the Ratio of Lymph Node Metastasis and the Reasonable Extent of Lymphadenectomy in Middle Third Thoracic Esophageal Squamous Cell Carcinoma
Ming-ran XIE, Peng LIN, Xu ZHANG, Jie-xin CHEN, Yong-bin LIN, Zhe-sheng WEN, Tie-hua RONG, Xiao-dong LI, Jun-ye WANG, Hui YU
Clinical Oncology and Cancer Research Feb 2010, 7 (1) 33-38; DOI: 10.1007/s11805-010-0033-y
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conflict of interest statement
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • B7-H4 Expression and Increased Death Risk of Cancer Patients: A Meta-Analysis
  • Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer
  • Pemetrexed Monotherapy and Pemetrexed Plus Platinum Combination Therapy as Non-First-Line Treatments for Advanced Non-Small Cell Lung Cancer
Show more Research Article

Similar Articles

Keywords

  • esophagus cancer
  • lymph nodes
  • metastasis
  • lymphadenectomy

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire